SARAH PASSMORE: Open Payments
NPI 1366002081 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,160 in 56 payments from 26 companies in 2025. Trend: 2023 $3,178 · 2024 $1,427 · 2025 $1,160
Food & beverage: $1,160
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $164 |
| Janssen Biotech, Inc. | 6 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $85 |
| Merck Sharp & Dohme LLC | 3 | $67 |
| Daiichi Sankyo Inc. | 3 | $65 |
| Incyte Corporation | 2 | $58 |
| Celgene Corporation | 3 | $55 |
| ABBVIE INC. | 3 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 2 | $40 |
Products named: KEYTRUDA, ERLEADA, MONJUVI, REBLOZYL, EPKINLY, Fabhalta, Nubeqa, NINLARO.
Industry payments across AL — which companies pay providers there.
